Touyun Biotech Clarifies Share Options Require Minimum 12-Month Vesting PeriodPUBT·Nov 17, 2026 at 09:34 AM01332-5.13%
Touyun Biotech Subsidiary Ronghe Times Establishes Joint R&D Center With Tianfu Yongxing LaboratoryPUBT·Oct 28, 2026 at 09:43 AM01332-5.13%
Touyun Biotech Grants 74.6 Million Share Options to Director and StaffTip Ranks·Sep 24, 2026 at 10:08 AM01332-5.13%
Touyun Biotech files next-day disclosure return in Hong Kong, issues 123 million new sharesPUBT·Sep 7, 2026 at 12:30 PM01332-5.13%
Touyun Biotech completes HK$15.01 million share placement at HK$0.122 per sharePUBT·Sep 7, 2026 at 12:25 PM01332-5.13%
Touyun Biotech details use of HK$14.99 million net proceeds from share subscriptionPUBT·Aug 31, 2026 at 12:24 PM01332-5.13%
Touyun Biotech FY26 H1 profit from continuing operations rises to HK$310.8 million; revenue falls 3.3% to HK$35.4 millionPUBT·Aug 28, 2026 at 12:06 PM01332-5.13%
Touyun Biotech expects H1 profit attributable to owners at HK$ 180 million-HK$ 200 millionPUBT·Aug 26, 2026 at 09:46 AM01332-5.13%